Literature DB >> 23274107

Pathobiology of rabies virus and the European bat lyssaviruses in experimentally infected mice.

D M Healy1, S M Brookes, A C Banyard, A Núñez, S L Cosby, A R Fooks.   

Abstract

A comparison of the clinicopathology of European bat lyssavirus (EBLV) types-1 and -2 and of rabies virus was undertaken. Following inoculation of mice at a peripheral site with these viruses, clinical signs of rabies and distribution of virus antigen in the mouse brain were examined. The appearance of clinical signs of disease varied both within and across the different virus species, with variation in incubation periods and weight loss throughout disease progression. The distribution of viral antigen throughout the regions of the brain examined was similar for each of the isolates during the different stages of disease progression, suggesting that antigen distribution was not associated with clinical presentation. However, specific regions of the brain including the cerebellum, caudal medulla, hypothalamus and thalamus, showed notable differences in the proportion of virus antigen positive cells present in comparison to other brain regions suggesting that these areas are important in disease development irrespective of virus species. Crown
Copyright © 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23274107     DOI: 10.1016/j.virusres.2012.12.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Establishment of a longitudinal pre-clinical model of lyssavirus infection.

Authors:  Kate E Mastraccio; Celeste Huaman; David Warrilow; Greg A Smith; Scott B Craig; Dawn L Weir; Eric D Laing; Ina L Smith; Christopher C Broder; Brian C Schaefer
Journal:  J Virol Methods       Date:  2020-05-12       Impact factor: 2.014

2.  Longitudinal Tracing of Lyssavirus Infection in Mice via In Vivo Bioluminescence Imaging.

Authors:  Kate E Mastraccio; Celeste Huaman; Eric D Laing; Christopher C Broder; Brian C Schaefer
Journal:  Methods Mol Biol       Date:  2022

3.  Comparative analysis of European bat lyssavirus 1 pathogenicity in the mouse model.

Authors:  Elisa Eggerbauer; Florian Pfaff; Stefan Finke; Dirk Höper; Martin Beer; Thomas C Mettenleiter; Tobias Nolden; Jens-Peter Teifke; Thomas Müller; Conrad M Freuling
Journal:  PLoS Negl Trop Dis       Date:  2017-06-19

4.  Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus.

Authors:  Rebecca Shipley; Edward Wright; Fabian Z X Lean; David Selden; Daniel L Horton; Anthony R Fooks; Ashley C Banyard
Journal:  Viruses       Date:  2021-05-20       Impact factor: 5.048

5.  Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus.

Authors:  Daniel L Horton; Ashley C Banyard; Denise A Marston; Emma Wise; David Selden; Alejandro Nunez; Daniel Hicks; Tiziana Lembo; Sarah Cleaveland; Alison J Peel; Ivan V Kuzmin; Charles E Rupprecht; Anthony R Fooks
Journal:  J Gen Virol       Date:  2014-02-04       Impact factor: 3.891

6.  Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2.

Authors:  Tiina Nokireki; Miia Jakava-Viljanen; Anna-Maija Virtala; Liisa Sihvonen
Journal:  Acta Vet Scand       Date:  2017-10-02       Impact factor: 1.695

7.  Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.

Authors:  Jennifer S Evans; Guanghui Wu; David Selden; Hubert Buczkowski; Leigh Thorne; Anthony R Fooks; Ashley C Banyard
Journal:  Viruses       Date:  2018-03-15       Impact factor: 5.048

8.  Comparative pathogenesis of different phylogroup I bat lyssaviruses in a standardized mouse model.

Authors:  Antonia Klein; Elisa Eggerbauer; Madlin Potratz; Luca M Zaeck; Sten Calvelage; Stefan Finke; Thomas Müller; Conrad M Freuling
Journal:  PLoS Negl Trop Dis       Date:  2022-01-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.